Actuate Therapeutics News and Activities

Actuate Therapeutics is a company listed under the stock ticker ACTU (US).

Acquisition, funding and merger involving Actuate Therapeutics.

• Actuate Therapeutics has filed its IPO. Its stock ticker will be ACTU. (posted on August 14 2024).

View the org chart displaying its 16 main executives

Most searched biographies at Actuate Therapeutics

• Daniel Schmitt, President, Chief Executive Officer and Director
• Jason Keyes, Director
• Martin Huber, Director

Popular executive movements at Actuate Therapeutics

• Martin Huber has joined the company as Director  (posted on May 6 2026).

Create your alert
to follow the executive moves at Actuate Therapeutics.

Actuate Therapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Actuate Therapeutics

• MEDIA | Actuate Therapeutics, Inc.
• MEDIA | Actuate Therapeutics, Inc.
• MEDIA | Actuate Therapeutics, Inc.
• MEDIA | Actuate Therapeutics, Inc.
• MEDIA | Actuate Therapeutics, Inc.
• News | Actuate Therapeutics, Inc.
• ACTUATE THERAPEUTICS ANNOUNCES POSTER PRESENTATIONS AT THE 2024 AACR ANNUAL MEETING | Actuate Therapeutics, Inc.
• ACTUATE THERAPEUTICS RECEIVES FDA ORPHAN DRUG DESIGNATION FOR  ELRAGLUSIB FOR TREATMENT OF PANCREATIC CANCER | Actuate Therapeutics, Inc.
• ACTUATE THERAPEUTICS ANNOUNCESPOSTER PRESENTATIONS AT THE 2023 ASCO ANNUAL MEETING | Actuate Therapeutics, Inc.
• ACTUATE THERAPEUTICS ANNOUNCES POSTER PRESENTATIONS AT THE 2023 AACR ANNUAL MEETING | Actuate Therapeutics, Inc.
• View more press releases Close

Social media about Actuate Therapeutics

• Actuate Therapeutics on Wikipedia, Google News & Yahoo Finance
• Actuate Therapeutics on LinkedIn, X (Twitter) & YouTube